NCT06247449View on ClinicalTrials.gov

MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 29, 2023

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2028

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

Brain imaging

Brain Magnetic resonance (or computed tomography if magnetic resonance is contraindicated)

DIAGNOSTIC_TEST

Analysis of circulating tumor DNA

One single blood draw for analysis of circulating tumor DNA

BEHAVIORAL

Testing Morbidities Index

Questionnaire regarding the participant's perception of brain imaging.

Trial Locations (1)

M4N 3M5

RECRUITING

Sunnybrook Health Science Centre, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

collaborator

MOUNT SINAI HOSPITAL

OTHER

collaborator

Trillium Health Partners

OTHER

lead

Sunnybrook Health Sciences Centre

OTHER